Your browser doesn't support javascript.
loading
The mechanism of resistance to CDK4/6 inhibition and novel combination therapy with RNR inhibition for chemo-resistant bladder cancer.
Tong, Zhichao; Zhao, Yubo; Bai, Shiyu; Ebner, Benedikt; Lienhard, Lou; Zhao, Yuling; Wang, Ziqi; Pan, Qi; Guo, Pengyu; Bracht, Thilo; Sitek, Barbara; Gschwend, Jürgen E; Xu, Wanhai; Nawroth, Roman.
Afiliación
  • Tong Z; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, P. R. China.
  • Zhao Y; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University, Harbin, Heilongjiang, P. R. China.
  • Bai S; Department of Urology, Klinikum rechts der Isar, Technical university of Munich, Munich, Germany.
  • Ebner B; Department of Urology, The Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang, P. R. China.
  • Lienhard L; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, P. R. China.
  • Zhao Y; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University, Harbin, Heilongjiang, P. R. China.
  • Wang Z; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University, Harbin, Heilongjiang, P. R. China.
  • Pan Q; Department of Urology, The Fourth Hospital of Harbin Medical University, Harbin, Heilongjiang, P. R. China.
  • Guo P; Department of Urology, Klinikum rechts der Isar, Technical university of Munich, Munich, Germany.
  • Bracht T; Department of Urology, Ludwig-Maximilians-University of Munich, Munich, Germany.
  • Sitek B; Department of Urology, Klinikum rechts der Isar, Technical university of Munich, Munich, Germany.
  • Gschwend JE; Department of Urology, Klinikum rechts der Isar, Technical university of Munich, Munich, Germany.
  • Xu W; Department of Urology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang, P. R. China.
  • Nawroth R; NHC and CAMS Key Laboratory of Molecular Probe and Targeted Theranostics, Harbin Medical University, Harbin, Heilongjiang, P. R. China.
Cancer Commun (Lond) ; 44(6): 700-704, 2024 Jun.
Article en En | MEDLINE | ID: mdl-38468431
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Resistencia a Antineoplásicos / Quinasa 4 Dependiente de la Ciclina / Quinasa 6 Dependiente de la Ciclina Límite: Humans Idioma: En Revista: Cancer Commun (Lond) Año: 2024 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Vejiga Urinaria / Resistencia a Antineoplásicos / Quinasa 4 Dependiente de la Ciclina / Quinasa 6 Dependiente de la Ciclina Límite: Humans Idioma: En Revista: Cancer Commun (Lond) Año: 2024 Tipo del documento: Article